1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis
(
- Contribution to journal › Article
- 2009
-
Mark
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.
(
- Contribution to journal › Article
-
Mark
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells
(
- Contribution to journal › Article
- 2008
-
Mark
Gene expression analysis of BCR/ABL1-dependent transcriptional response reveals enrichment for genes involved in negative feedback regulation.
(
- Contribution to journal › Article
- 2006
-
Mark
Catabolism of pyrimidines in yeast: A tool to understand degradation of anticancer drugs
(
- Contribution to journal › Article
-
Mark
Thymidine kinase diversity in bacteria
(
- Contribution to journal › Article
-
Mark
Induction chemotherapy and post-remission imatinib therapy for de Novo BCR-ABL-positive AML
(
- Contribution to journal › Article
- 2003
-
Mark
2,2 '-nitrophenylisatogen potentiates P2X(1) receptor mediated vascular contraction and blood pressure elevation
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding